Race to Four Trillion
Invest in the companies building the foundation of the AI revolution. These carefully selected stocks represent crucial suppliers and enablers benefiting from Nvidia and Microsoft's historic race to $4 trillion valuations and their unprecedented spending on AI infrastructure.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
ASML Holding NV
ASML
Current price
$743.61
Provides the essential and monopolistic EUV lithography machines required by foundries like TSMC to produce the next-generation chips powering the AI ...
Provides the essential and monopolistic EUV lithography machines required by foundries like TSMC to produce the next-generation chips powering the AI boom.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
As Nvidia and Microsoft compete for $4T valuations, they're pouring billions into AI infrastructure. This massive spending creates a ripple effect, benefiting the entire supply chain of companies that provide the essential hardware, software, and facilities needed to build the AI economy.
What You Need to Know
This collection focuses on companies across the entire AI technology value chain – from chip manufacturing and design to data centers and power management. These stocks offer exposure to the durable growth cycle created by the unprecedented capital investment in artificial intelligence infrastructure.
Why These Stocks
These companies were selected because they provide critical components and services that the AI giants can't build without. From advanced semiconductors and high-bandwidth memory to specialized cooling systems and networking equipment, each plays an essential role in the expanding AI ecosystem.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+15.47%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 15.47% over the next year.
Stocks Rated Buy by Analysts
15 of 16 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.7% return last month.
Why You'll Want to Watch These Stocks
The $1 Trillion Spending Wave
Microsoft, Nvidia, and other tech giants are pouring unprecedented billions into AI infrastructure. These suppliers are the direct beneficiaries of this massive capital allocation, creating a durable growth cycle.
Beyond the Obvious AI Names
While everyone focuses on Nvidia and Microsoft, these essential suppliers often fly under the radar despite their critical role in the AI ecosystem. These companies represent the "picks and shovels" of the AI gold rush.
The Entire Tech Value Chain
This collection spans the full technology value chain - from advanced chip manufacturing and design software to data centers and the power infrastructure required to run them. It's a comprehensive way to invest in all aspects of the AI buildout.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.